TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Study 200622: A Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of Mepolizumab in the Treatment of Adolescent and Adult Subjects With Severe Hypereosinophilic Syndrome
Brief Summary: Mepolizumab is a humanized monoclonal antibody. In conditions where eosinophilia is considered to play an important part in the pathology, including eosinophilic asthma, HES, and eosinophilic granulomatosis with polyangiitis, a consistent reduction in blood eosinophil counts is observed in association with mepolizumab administration, with concomitant clinical improvement. This is a 32-week treatment period, randomized, double-blind, placebo-controlled, parallel group, multicentre study of mepolizumab in adolescent and adult subjects with severe HES receiving standard of care (SoC) therapy. This study will demonstrate the efficacy of mepolizumab compared with placebo based on maintenance of control of HES symptoms during the treatment period. The study will comprise of a screening period of up to approximately 4 weeks followed by a 32-Week study treatment period (subjects will be randomized 1:1 to placebo or mepolizumab) and up to 8-week additional follow-up period (12 weeks after the last dose of study treatment).


Options:
A: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Active; Type: ACTIVE_COMPARATOR; Interventions: Drug: GSK679586 | Intervention Type: DRUG; Name: GSK679586; Assigned to Arm(s): Active | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Intervention Type: DRUG; Name: SB-240563 (Mepolizumab); Assigned to Arm(s): N/A
C: Arm Label: Mepolizumab; Type: EXPERIMENTAL; Interventions: Drug: Mepolizumab 300 mg, Drug: Active OCS capsules (5 mg prednisolone or prednisone), Drug: Placebo matching OCS capsules | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo matching mepolizumab, Drug: Active OCS capsules (5 mg prednisolone or prednisone), Drug: Placebo matching OCS capsules | Intervention Type: DRUG; Name: Mepolizumab 300 mg; Assigned to Arm(s): Mepolizumab | Intervention Type: DRUG; Name: Placebo matching mepolizumab; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Active OCS capsules (5 mg prednisolone or prednisone); Assigned to Arm(s): Mepolizumab, Placebo | Intervention Type: DRUG; Name: Placebo matching OCS capsules; Assigned to Arm(s): Mepolizumab, Placebo
D: Arm Label: Benralizumab Arm A; Type: EXPERIMENTAL; Interventions: Biological: Benralizumab | Arm Label: Benralizumab Arm B; Type: EXPERIMENTAL; Interventions: Biological: Benralizumab | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo | Intervention Type: BIOLOGICAL; Name: Benralizumab; Assigned to Arm(s): Benralizumab Arm A | Intervention Type: BIOLOGICAL; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: BIOLOGICAL; Name: Benralizumab; Assigned to Arm(s): Benralizumab Arm B

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: Background: Over 39% of approximately 3,000 doctors (The British Medical Association quarterly survey, 2015) admitted to frequently feeling drained, exhausted, overloaded, tired, low and lacking energy. Such occupational distress may link to psychological and physical difficulties in doctors and have negative outcomes for organization and patients. The aim of the current study is to investigate the impact of an induction programme on occupational distress of doctors.

Methods/design: Doctors will be invited to take part in an online research. Participants will be randomly assigned to the experimental and control groups. Participants in the experimental groups will complete one of the induction topics (about stress at work). Before and after an induction programme participants will be asked to fill in an online survey about their current occupational distress and organizational well-being.

Discussion: The investigators expect that doctors' psychological, physiological and organizational well-being will improve after an induction programme which should serve as a resource for better doctor's own health understanding.


Options:
A: Arm Label: Induction; Type: EXPERIMENTAL; Interventions: Other: Induction | Arm Label: Control group; Type: OTHER; Interventions: Other: Control group | Intervention Type: OTHER; Name: Induction; Assigned to Arm(s): Induction | Intervention Type: OTHER; Name: Control group; Assigned to Arm(s): Control group
B: Arm Label: ACT; Type: EXPERIMENTAL; Interventions: Other: Acceptance and Commitment Therapy (ACT) | Arm Label: WPI; Type: EXPERIMENTAL; Interventions: Other: workplace intervention (WPI) | Arm Label: ACT and WPI; Type: EXPERIMENTAL; Interventions: Other: Acceptance and Commitment Therapy (ACT), Other: workplace intervention (WPI) | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Acceptance and Commitment Therapy (ACT); Assigned to Arm(s): ACT, ACT and WPI | Intervention Type: OTHER; Name: workplace intervention (WPI); Assigned to Arm(s): ACT and WPI, WPI
C: Arm Label: Mental Training for Surgeons; Type: EXPERIMENTAL; Interventions: Behavioral: Mindfulness Based Stress Reduction - modified | Arm Label: The Mind of a Surgeon; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Active listening and reading | Intervention Type: BEHAVIORAL; Name: Mindfulness Based Stress Reduction - modified; Assigned to Arm(s): Mental Training for Surgeons | Intervention Type: BEHAVIORAL; Name: Active listening and reading; Assigned to Arm(s): The Mind of a Surgeon
D: Arm Label: Mindfulness training; Type: EXPERIMENTAL; Interventions: Behavioral: Mindfulness training | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Mindfulness training; Assigned to Arm(s): Mindfulness training

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: Background: Over 39% of approximately 3,000 doctors (The British Medical Association quarterly survey, 2015) admitted to frequently feeling drained, exhausted, overloaded, tired, low and lacking energy. Such occupational distress may link to psychological and physical difficulties in doctors and have negative outcomes for organization and patients. The aim of the current study is to investigate the impact of an induction programme on occupational distress of doctors.

Methods/design: Doctors will be invited to take part in an online research. Participants will be randomly assigned to the experimental and control groups. Participants in the experimental groups will complete one of the induction topics (about stress at work). Before and after an induction programme participants will be asked to fill in an online survey about their current occupational distress and organizational well-being.

Discussion: The investigators expect that doctors' psychological, physiological and organizational well-being will improve after an induction programme which should serve as a resource for better doctor's own health understanding.


Options:
A: Arm Label: Induction; Type: EXPERIMENTAL; Interventions: Other: Induction | Arm Label: Control group; Type: OTHER; Interventions: Other: Control group | Intervention Type: OTHER; Name: Induction; Assigned to Arm(s): Induction | Intervention Type: OTHER; Name: Control group; Assigned to Arm(s): Control group
B: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Corporate Athlete Resilience (CAR) Training Program | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Corporate Athlete Resilience (CAR) Training Program; Assigned to Arm(s): Intervention
C: Arm Label: Group therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Manualized Therapy | Arm Label: Control Group; Type: OTHER; Interventions: Behavioral: Control Group | Intervention Type: BEHAVIORAL; Name: Manualized Therapy; Assigned to Arm(s): Group therapy | Intervention Type: BEHAVIORAL; Name: Control Group; Assigned to Arm(s): Control Group
D: Arm Label: Short-term Compassion Fatigue Resiliency Program; Type: EXPERIMENTAL; Interventions: Behavioral: Compassion Fatigue Resiliency Program (CFRP) | Arm Label: Long-term Compassion Fatigue Resiliency Program; Type: EXPERIMENTAL; Interventions: Behavioral: Compassion Fatigue Resiliency Program (CFRP) | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Compassion Fatigue Resiliency Program (CFRP); Assigned to Arm(s): Long-term Compassion Fatigue Resiliency Program, Short-term Compassion Fatigue Resiliency Program

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Gait Pattern Analysis and Feasibility of Gait Training With a Newly Developed Walking Assist Robot in Stroke Patients and Elderly Adults
Brief Summary: The purpose of this study was to investigate the effects of the new wearable hip assist robot developed by Samsung Advanced Institute of Technology (Samsung Electronics Co, Ltd., Korea) to gait rehabilitation in elderly adults and stroke patients.


Options:
A: Arm Label: Robot, then conventional training; Type: EXPERIMENTAL; Interventions: Other: Robot, then conventional training | Arm Label: Conventional, then robot training; Type: ACTIVE_COMPARATOR; Interventions: Other: Conventional, then robot training | Intervention Type: OTHER; Name: Robot, then conventional training; Assigned to Arm(s): Robot, then conventional training | Intervention Type: OTHER; Name: Conventional, then robot training; Assigned to Arm(s): Conventional, then robot training
B: Arm Label: Samsung Hip Assist v1; Type: EXPERIMENTAL; Interventions: Device: gait rehabilitation with Samsung Hip Assist v1 | Arm Label: Conventional gait training; Type: ACTIVE_COMPARATOR; Interventions: Other: gait rehabilitation without Samsung Hip Assist v1 | Intervention Type: DEVICE; Name: gait rehabilitation with Samsung Hip Assist v1; Assigned to Arm(s): Samsung Hip Assist v1 | Intervention Type: OTHER; Name: gait rehabilitation without Samsung Hip Assist v1; Assigned to Arm(s): Conventional gait training
C: Arm Label: Ekso training; Type: EXPERIMENTAL; Interventions: Device: EKso training | Arm Label: Overground training; Type: ACTIVE_COMPARATOR; Interventions: Device: EKso training | Intervention Type: DEVICE; Name: EKso training; Assigned to Arm(s): Ekso training, Overground training
D: Arm Label: Exoskeleton Program; Type: EXPERIMENTAL; Interventions: Device: Exoskeleton Program | Arm Label: Usual Care Program; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual Care Program | Intervention Type: DEVICE; Name: Exoskeleton Program; Assigned to Arm(s): Exoskeleton Program | Intervention Type: OTHER; Name: Usual Care Program; Assigned to Arm(s): Usual Care Program

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Observational Study on Smoking Cessation and Cost Outcomes in the Duke Smoking Cessation Program
Brief Summary: The purpose of this study is to conduct an observational assessment of natural outcomes within the Duke Smoking Cessation Program (DSCP), "Quit at Duke." This assessment will include information regarding abstinence rates, changes in patient emotional state following treatment, and costs of operations. Primarily, this study will assess the financial sustainability and the cost-effectiveness of the program.


Options:
A: Arm Label: P; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Drug: Bupropion HCl ER | Intervention Type: DRUG; Name: Bupropion HCl ER; Assigned to Arm(s): A | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): P
B: Arm Label: Participants; Type: N/A; Interventions: N/A
C: Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: varenicline; Type: ACTIVE_COMPARATOR; Interventions: Drug: varenicline tartrate | Arm Label: bupropion; Type: ACTIVE_COMPARATOR; Interventions: Drug: bupropion hydrochloride | Arm Label: Nicotine Replacement Therapy Patch; Type: ACTIVE_COMPARATOR; Interventions: Drug: Nicotine Replacement Therapy Patch | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): placebo | Intervention Type: DRUG; Name: varenicline tartrate; Assigned to Arm(s): varenicline | Intervention Type: DRUG; Name: bupropion hydrochloride; Assigned to Arm(s): bupropion | Intervention Type: DRUG; Name: Nicotine Replacement Therapy Patch; Assigned to Arm(s): Nicotine Replacement Therapy Patch
D: Arm Label: Intervention arm; Type: EXPERIMENTAL; Interventions: Behavioral: intensive multi-disciplinary education program on tobacco treatment for pharmacists | Arm Label: Control arm; Type: ACTIVE_COMPARATOR; Interventions: Other: Control arm | Intervention Type: BEHAVIORAL; Name: intensive multi-disciplinary education program on tobacco treatment for pharmacists; Assigned to Arm(s): Intervention arm | Intervention Type: OTHER; Name: Control arm; Assigned to Arm(s): Control arm

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Observational Study on Smoking Cessation and Cost Outcomes in the Duke Smoking Cessation Program
Brief Summary: The purpose of this study is to conduct an observational assessment of natural outcomes within the Duke Smoking Cessation Program (DSCP), "Quit at Duke." This assessment will include information regarding abstinence rates, changes in patient emotional state following treatment, and costs of operations. Primarily, this study will assess the financial sustainability and the cost-effectiveness of the program.


Options:
A: Intervention Type: DRUG; Name: varenicline (CP-526,555); Assigned to Arm(s): N/A
B: Arm Label: Osmotic-Release Methylphenidate; Type: ACTIVE_COMPARATOR; Interventions: Drug: Osmotic-Release Methylphenidate | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Osmotic-Release Methylphenidate; Assigned to Arm(s): Osmotic-Release Methylphenidate | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Standard Care plus Wellness Program; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Cognitive Behavioral Treatment, Drug: Nicotine Patch, Behavioral: Wellness Program | Arm Label: Standard Care plus Exercise Program; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Cognitive Behavioral Treatment, Drug: Nicotine Patch, Behavioral: Aerobic Exercise | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Treatment; Assigned to Arm(s): Standard Care plus Exercise Program, Standard Care plus Wellness Program | Intervention Type: DRUG; Name: Nicotine Patch; Assigned to Arm(s): Standard Care plus Exercise Program, Standard Care plus Wellness Program | Intervention Type: BEHAVIORAL; Name: Wellness Program; Assigned to Arm(s): Standard Care plus Wellness Program | Intervention Type: BEHAVIORAL; Name: Aerobic Exercise; Assigned to Arm(s): Standard Care plus Exercise Program
D: Arm Label: Participants; Type: N/A; Interventions: N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Observational Study on Smoking Cessation and Cost Outcomes in the Duke Smoking Cessation Program
Brief Summary: The purpose of this study is to conduct an observational assessment of natural outcomes within the Duke Smoking Cessation Program (DSCP), "Quit at Duke." This assessment will include information regarding abstinence rates, changes in patient emotional state following treatment, and costs of operations. Primarily, this study will assess the financial sustainability and the cost-effectiveness of the program.


Options:
A: Arm Label: varenicline; Type: ACTIVE_COMPARATOR; Interventions: Drug: varenicline tartrate (CP-526, 555-18) | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: varenicline tartrate (CP-526, 555-18); Assigned to Arm(s): varenicline | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): placebo
B: Arm Label: varenicline; Type: ACTIVE_COMPARATOR; Interventions: Drug: varenicline | Arm Label: control group; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo tablet is made of lactose | Intervention Type: DRUG; Name: varenicline; Assigned to Arm(s): varenicline | Intervention Type: DRUG; Name: placebo tablet is made of lactose; Assigned to Arm(s): control group
C: Arm Label: Participants; Type: N/A; Interventions: N/A
D: Arm Label: Bupropion SR; Type: ACTIVE_COMPARATOR; Interventions: Drug: Bupropion SR | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo Oral Tablet | Intervention Type: DRUG; Name: Bupropion SR; Assigned to Arm(s): Bupropion SR | Intervention Type: DRUG; Name: Placebo Oral Tablet; Assigned to Arm(s): Placebo

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Observational Study on Smoking Cessation and Cost Outcomes in the Duke Smoking Cessation Program
Brief Summary: The purpose of this study is to conduct an observational assessment of natural outcomes within the Duke Smoking Cessation Program (DSCP), "Quit at Duke." This assessment will include information regarding abstinence rates, changes in patient emotional state following treatment, and costs of operations. Primarily, this study will assess the financial sustainability and the cost-effectiveness of the program.


Options:
A: Arm Label: Experimental; Type: EXPERIMENTAL; Interventions: Behavioral: Smartphone-delivered Intervention (SmartQuit) | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: : Smartphone-delivered Intervention (Standard of care app) | Intervention Type: BEHAVIORAL; Name: Smartphone-delivered Intervention (SmartQuit); Assigned to Arm(s): Experimental | Intervention Type: BEHAVIORAL; Name: : Smartphone-delivered Intervention (Standard of care app); Assigned to Arm(s): Control
B: Arm Label: Participants; Type: N/A; Interventions: N/A
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: yoga, Behavioral: cognitive therapy | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: cognitive therapy, Behavioral: wellness | Intervention Type: BEHAVIORAL; Name: yoga; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: cognitive therapy; Assigned to Arm(s): 1, 2 | Intervention Type: BEHAVIORAL; Name: yoga; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: wellness; Assigned to Arm(s): 2
D: Arm Label: Experimental App; Type: EXPERIMENTAL; Interventions: Behavioral: Experimental App | Arm Label: Active comparator app; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Active Comparator App | Intervention Type: BEHAVIORAL; Name: Experimental App; Assigned to Arm(s): Experimental App | Intervention Type: BEHAVIORAL; Name: Active Comparator App; Assigned to Arm(s): Active comparator app

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Improvement of Acute Pain Treatment With Systemic and Regional Anesthesia
Brief Summary: The German Network for acute pain management and Regional Anesthesia (NRA) is a multi-center, non-interventional registry and benchmark project, assessing and analysing clinical and patient-reported procedural and outcome data of systemic analgesia and regional anesthesia hosted by the German Society of Anesthesia and Intensive Care Medicine (DGAI) and professional Society German Anesthetists (BDA)


Options:
A: Arm Label: Fascia iliaca block; Type: EXPERIMENTAL; Interventions: Procedure: Fascia iliaca block | Arm Label: Sham injection; Type: SHAM_COMPARATOR; Interventions: Procedure: Sham injection | Intervention Type: PROCEDURE; Name: Fascia iliaca block; Assigned to Arm(s): Fascia iliaca block | Intervention Type: PROCEDURE; Name: Sham injection; Assigned to Arm(s): Sham injection
B: Arm Label: Ropivacaine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Ropivacaine | Arm Label: Saline; Type: PLACEBO_COMPARATOR; Interventions: Drug: Ropivacaine | Intervention Type: DRUG; Name: Ropivacaine; Assigned to Arm(s): Ropivacaine, Saline
C: Arm Label: Standard Treatment; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Continuous fascia iliaca block; Type: EXPERIMENTAL; Interventions: Procedure: Continuous fascia iliaca block, Drug: Ropivacaine | Intervention Type: PROCEDURE; Name: Continuous fascia iliaca block; Assigned to Arm(s): Continuous fascia iliaca block | Intervention Type: DRUG; Name: Ropivacaine; Assigned to Arm(s): Continuous fascia iliaca block
D: Arm Label: regional anesthesia; Type: N/A; Interventions: N/A | Arm Label: systemic analgesia; Type: N/A; Interventions: N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Targeted Adherence Intervention to Reach Glycemic Control With Insulin Therapy for Patients With Diabetes (TARGIT-DM)
Brief Summary: The purpose of this study is to evaluate three pharmacist-outreach strategies for improving adherence to insulin among individuals with diabetes. The three approaches are equivalently-priced but vary by degree of targeting and intervention intensity.


Options:
A: Arm Label: ATSM Intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: ATSM Intervention | Arm Label: GMV Intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: GMV Intervention | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: ATSM Intervention; Assigned to Arm(s): ATSM Intervention | Intervention Type: BEHAVIORAL; Name: GMV Intervention; Assigned to Arm(s): GMV Intervention
B: Arm Label: Reciprocal Diabetes Peer Support program; Type: EXPERIMENTAL; Interventions: Behavioral: Reciprocal Diabetes Peer Support Program, Behavioral: group outpatient counseling visits | Arm Label: Nurse Case Management; Type: OTHER; Interventions: Behavioral: Nurse Case management | Intervention Type: BEHAVIORAL; Name: Reciprocal Diabetes Peer Support Program; Assigned to Arm(s): Reciprocal Diabetes Peer Support program | Intervention Type: BEHAVIORAL; Name: Nurse Case management; Assigned to Arm(s): Nurse Case Management | Intervention Type: BEHAVIORAL; Name: group outpatient counseling visits; Assigned to Arm(s): Reciprocal Diabetes Peer Support program
C: Arm Label: Low intensity; Type: ACTIVE_COMPARATOR; Interventions: Other: Low intensity | Arm Label: Moderate intensity; Type: EXPERIMENTAL; Interventions: Other: Moderate intensity | Arm Label: High intensity; Type: EXPERIMENTAL; Interventions: Other: High intensity | Intervention Type: OTHER; Name: Low intensity; Assigned to Arm(s): Low intensity | Intervention Type: OTHER; Name: Moderate intensity; Assigned to Arm(s): Moderate intensity | Intervention Type: OTHER; Name: High intensity; Assigned to Arm(s): High intensity
D: Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Telemedicine; Type: EXPERIMENTAL; Interventions: Device: Telemedicine | Intervention Type: DEVICE; Name: Telemedicine; Assigned to Arm(s): Telemedicine

Answer: C